Category Archives: Transhuman News

Managing childhood eczema seminar, 5 of 8. Skin infections and eczema
Video from the one-day PHARMAC seminar on practical management of childhood eczema held in Wellington, New Zealand, on 17 November 2014. 1. "Why does eczema ...

By: PHARMACgovtnz

Go here to see the original:
Managing childhood eczema seminar, 5 of 8. Skin infections and eczema - Video

aveeno anti itch cream eczema
This will help you. Get the product here: http://qps.ru/jkyvz.

By: Dahsa Krypko

Continued here:
aveeno anti itch cream eczema - Video

Jonestown - Sugar Ship b/w Eczema - 45 Single
Jonestown A Side: Sugar Ship B Side: Eczema Project A-Bomb Records, A-BOMB 001 1990 "My name is eczema. You #39;ll never sleep again." Sometimes just the simples...

By: MN 45s

Here is the original post:
Jonestown - Sugar Ship b/w Eczema - 45 Single - Video

New Aveeno Baby Cleansing Eczema Therapy Moisturizing Wash Scent Top List
Check out: http://amzn.to/1KAMi0d Aveeno Baby Cleansing Eczema Therapy Moisturizing Wash Scent Are you planning to buy a new Aveeno Baby Cleansing Eczema Therapy Moisturizing Wash Scent ...

By: Dewi Pertiwi

See the original post:
New Aveeno Baby Cleansing Eczema Therapy Moisturizing Wash Scent Top List - Video

Get California Baby Eczema Shampoo Bodywash - No Fragrance The (Review)
Browse through: http://amzn.to/1KFddrH California Baby Eczema Shampoo Bodywash - No Fragrance The Are you preparing to buy a new California Baby Eczema Shampoo Bodywash - No ...

By: Beso Klagy

Read the rest here:
Get California Baby Eczema Shampoo & Bodywash - No Fragrance The (Review) - Video

New Michaderm Eczema Flare Defense Calming Cream, for Baby Eczem (Review)
See: http://amzn.to/1A8Avw5 Michaderm Eczema Flare Defense Calming Cream, for Baby Eczem Are you intending to get a brand-new Michaderm Eczema Flare Defense Calming Cream, for Baby ...

By: Kemare Nsore

Visit link:
New Michaderm Eczema Flare Defense Calming Cream, for Baby Eczem (Review) - Video

Adults with the common chronic skin condition eczema had higher out-of-pocket health care costs, more lost workdays, poorer overall health, more health care utilization and impaired access to care compared to adults without eczema, according to an article published online by JAMA Dermatology.

The prevalence of adult eczema (or atopic dermatitis, AD) is estimated to be about 10.2 percent in U.S. adults and similarly about 10.7 percent in U.S. children. However, little is known about the direct and indirect costs of adult eczema and recent cost estimates for the disease are lacking, according to the study background.

Jonathan I. Silverberg, M.D., Ph.D, M.P.H., of the Northwestern University Feinberg School of Medicine, Chicago, examined those costs by analyzing data from two population-based studies between 2010 and 2012 that surveyed 27,157 and 34,613 adults, respectively.

The study results show that adults with eczema paid more than $37.7 billion and $29.3 billion in out-of-pocket health care costs in 2010 and 2012, respectively (an average of $371 and $489 per person-year). Adults with eczema also were more likely to have six or more lost workdays due to any cause than those adults without eczema, and having eczema was associated with increased odds of physician visits, urgent care or emergency department visits, and hospitalizations. There also were differences in access to care, including adults with eczema being unable to afford prescription medications and having higher odds of delayed care because they cannot get a medical appointment soon enough, reach a physician's office or having to wait too long to see a physician. Adults with eczema also were more likely to have delayed care or no care because of worry about the related costs, according to the results.

"This study demonstrates that adults with eczema have a major health burden with significantly increased health care utilization and costs. Future studies are needed to identify the determinants of health care utilization and access in adults with eczema," the study concludes.

###

(JAMA Dermatology. Published online march 4, 2015. doi:10.1001/jamadermatol.2014.5432. Available pre-embargo to the media at http://media.jamanetwork.com.)

Editor's Note: This study was made possible with support from the Agency for Healthcare Research and Quality. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Media Advisory: To contact author Jonathan I. Silverberg, M.D., Ph.D., M.P.H., call Marla Paul at 312-503-8928 or email marla-paul@northwestern.edu.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.

The rest is here:
Study quantifies costs, utilization, access to care for patients with eczema